BioStem Technologies to Present at Global Investment Conference

POMPANO BEACH, Fla., Sept. 03, 2026 /CourierPR/ -- BioStem Technologies Inc., a leading regenerative medicine company, will present at the 28th Annual Global Investment Conference organized by H.C. Wainwright, held in New York on September 14. The company's management team will deliver a fireside chat that will be accessible online on September 11, 2026, at 7:00 AM Eastern Time.

Founded as a publicly traded biomedical innovator, BioStem Technologies focuses on advanced allograft solutions derived from perinatal tissue. The company utilizes its proprietary BioRetain®, CryoTek®, and SteriTek® processing technologies to preserve the natural properties of these tissues, ensuring their effectiveness in clinical settings. Its portfolio includes Neox®, Clarix®, VENDAJE®, and American Amnion™, used by clinicians across various specialties.

BioStem Technologies has demonstrated its commitment to quality and compliance by earning accreditation from the Association for Advancing Tissue and Biologics (AATB). The company's quality management system and standard operating procedures adhere to current Good Tissue Practices (cGTP) and current Good Manufacturing Practices (cGMP).